About: Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.75 (-1.69%)
LGVN NASDAQ Longeveron LLC
Longeveron LLC share price
Atividade de preço de LGVN
Último preço
$ 1,750
Variação (24h)
-0,03 USD (1,69%)
Volume
62.77K
Volume (média 4 sem.)
-
Abertura
$ 1,73
Variação do dia
$ 1,73 - $ 1,83
Fechamento anterior
$ 1,78
Último negócio
29 Oct, 8:09 pm GMT+0
Atrasado
29 Oct, 8:09 pm GMT+0
LGVN price performance
Atrasado
29 Oct, 8:09 pm GMT+0
quote.marketSignals